Last updated: October 25, 2023
Sponsor: Taichung Veterans General Hospital
Overall Status: Completed
Phase
2
Condition
Common Cold
Allergy
Nasal Obstruction
Treatment
Szechwan Lovage Rhizome, Biod Magnolia Bud, Taiwan Angelica Root, Wild Mint Herb, Baikal Skullcap Root, and Borneol
edible caramel
Clinical Study ID
NCT05901532
CF19289A
Ages > 20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Allergic rhinitis patients diagnosed based on the history and allergen test
Exclusion
Exclusion Criteria:
- Those younger than 20 years old, Immunocompromised patients Pregnant women orbreastfeeding women Those with a history of allergy to traditional Chinese medicineThose with liver and kidney insufficiency Those who cannot cooperate with nasalirrigation
Study Design
Total Participants: 38
Treatment Group(s): 2
Primary Treatment: Szechwan Lovage Rhizome, Biod Magnolia Bud, Taiwan Angelica Root, Wild Mint Herb, Baikal Skullcap Root, and Borneol
Phase: 2
Study Start date:
November 01, 2020
Estimated Completion Date:
February 28, 2023
Study Description
Connect with a study center
Rong-San Jiang
Taichung, 40705
TaiwanSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.